Free Trial
→ Now I look stupid. Real stupid... (From Porter & Company) (Ad) Buy GRCE Stock  Free GRCE Stock Alerts

Grace Therapeutics (GRCE) SEC Filings & 10K Form

Grace Therapeutics logo
$2.09 +0.05 (+2.45%)
As of 04/17/2025 04:00 PM Eastern
Compare

Recent Grace Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/16/2025
7:58 PM		D'Andrea Carrie (Reporting)
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM		Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Kohli Prashant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM		DelAversano Robert J (Reporting)
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM		Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Macdonald R. Loch (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM		Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Kumar Amresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
7:00 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
11:15 PM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
03/10/2025
6:58 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/03/2025
7:00 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
2:05 PM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
02/18/2025
7:25 PM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q/A
02/13/2025
7:00 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
6:30 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/10/2025
7:11 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
5:13 AM		Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
11/14/2024
10:58 AM		BANK OF AMERICA CORP /DE/ (Filed by)
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
Form SC 13G/A
11/13/2024
7:00 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:30 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
7:22 AM		Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:13 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
11:15 PM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
10/15/2024
11:15 PM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
10/08/2024
6:22 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/08/2024
6:13 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form POS AM
10/08/2024
6:15 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form POS AM
10/08/2024
6:16 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
10/08/2024
6:16 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
10/08/2024
6:16 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
09/30/2024
3:31 PM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
7:00 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:00 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:30 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:14 PM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 424B3
08/04/2024
11:15 PM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
07/31/2024
6:22 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-4/A
07/11/2024
10:16 AM		Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Form 3/A
07/10/2024
8:10 PM		Acasti Pharma Inc. (Subject)
Grace Therapeutics (Subject)
ADAR1 Capital Management, LLC (Filed by)
Form SC 13G
07/09/2024
7:29 PM		Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
4:01 PM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
06/21/2024
7:00 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
6:30 AM		Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Trump’s Top Secret $9 Trillion AI Superweapon (Ad)

Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that could benefit.

Nvidia’s early days made millionaires. This AI play might too.
05/08/2024
6:18 PM		Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Kohli Prashant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:18 PM		Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
DelAversano Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM		Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Macdonald R. Loch (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM		Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
Kumar Amresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:19 PM		Acasti Pharma Inc. (Issuer)
Grace Therapeutics (Issuer)
D'Andrea Carrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:GRCE) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Trump’s Top Secret $9 Trillion AI Superweapon
Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...
Brownstone Research | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
Claim Your FREE Protection Guide
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...
American Alternative | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored